Multidisciplinary management of acromegaly: A consensus

Carregando...
Imagem de Miniatura
Citações na Scopus
172
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
GIUSTINA, Andrea
BARKHOUDARIAN, Garni
BECKERS, Albert
BEN-SHLOMO, Anat
BIERMASZ, Nienke
BILLER, Beverly
BOGUSZEWSKI, Cesar
BOLANOWSKI, Marek
BOLLERSLEV, Jens
BONERT, Vivien
Citação
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, v.21, n.4, p.667-678, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The 13th Acromegaly Consensus Conference was held in November 2019 in Fort Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and neurosurgeons who considered optimal approaches for multidisciplinary acromegaly management. Focused discussions reviewed techniques, results, and side effects of surgery, radiotherapy, and medical therapy, and how advances in technology and novel techniques have changed the way these modalities are used alone or in combination. Effects of treatment on patient outcomes were considered, along with strategies for optimizing and personalizing therapeutic approaches. Expert consensus recommendations emphasize how best to implement available treatment options as part of a multidisciplinary approach at Pituitary Tumor Centers of Excellence.
Palavras-chave
Acromegaly, Consensus, Multidisciplinary management, Medical therapy, Surgery, Radiotherapy, Pituitary tumor centers of excellence
Referências
  1. Agrawal N, 2020, PITUITARY, V23, P582, DOI 10.1007/s11102-020-01063-x
  2. Albarel F, 2018, PITUITARY, V21, P615, DOI 10.1007/s11102-018-0916-0
  3. Almeida JP, 2018, J NEUROSURG, V129, P404, DOI 10.3171/2017.2.JNS162673
  4. Alquraini H, 2018, PITUITARY, V21, P283, DOI 10.1007/s11102-018-0867-5
  5. Amano K, 2019, ACTA NEUROCHIR, V161, P695, DOI 10.1007/s00701-018-03778-0
  6. Amato G, 2002, CLIN ENDOCRINOL, V56, P65, DOI 10.1046/j.0300-0664.2001.01438.x
  7. Antunes X, 2018, ENDOCRINE, V60, P415, DOI 10.1007/s12020-018-1590-8
  8. Basavilbaso NXG, 2019, ARCH ENDOCRIN METAB, V63, P320, DOI 10.20945/2359-3997000000160
  9. Bernabeu I, 2013, PITUITARY, V16, P101, DOI 10.1007/s11102-012-0382-z
  10. Bianchi A, 2009, J CLIN ENDOCR METAB, V94, P2015, DOI 10.1210/jc.2008-1337
  11. Biermasz NR, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101309
  12. Boguszewski CL, 2019, ARCH ENDOCRIN METAB, V63, P328, DOI 10.20945/2359-3997000000159
  13. Bohl MA, 2016, NEUROSURGERY, V78, P84, DOI 10.1227/NEU.0000000000001003
  14. Brue T, 2019, ENDOCRINE, V63, P563, DOI 10.1007/s12020-018-1792-0
  15. Buchfelder M, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101299
  16. Buchfelder M, 2018, EUR J ENDOCRINOL, V179, P419, DOI 10.1530/EJE-18-0616
  17. Buttan A, 2019, NEUROSURG CLIN N AM, V30, P491, DOI 10.1016/j.nec.2019.05.009
  18. Carmichael JD, 2009, J CLIN ENDOCR METAB, V94, P523, DOI 10.1210/jc.2008-1371
  19. Caron PJ, 2014, J CLIN ENDOCR METAB, V99, P1282, DOI 10.1210/jc.2013-3318
  20. Casanueva FF, 2017, PITUITARY, V20, P489, DOI 10.1007/s11102-017-0838-2
  21. Chen CJ, 2017, ACTA NEUROCHIR, V159, P2193, DOI 10.1007/s00701-017-3318-6
  22. Chiloiro S, 2020, J CLIN ENDOCR METAB, V105, pE100, DOI 10.1210/clinem/dgz054
  23. Chiloiro S, 2019, J CLIN ENDOCR METAB, V104, P5478, DOI 10.1210/jc.2019-00825
  24. Clemmons DR, 2007, PITUITARY, V10, P121, DOI 10.1007/s11102-007-0032-z
  25. Colao A, 2014, J CLIN ENDOCR METAB, V99, P791, DOI 10.1210/jc.2013-2480
  26. Colao Annamaria, 2020, Eur J Endocrinol, V182, P583, DOI 10.1530/EJE-19-0762
  27. Colao A, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0071-6
  28. Colao A, 2016, PITUITARY, V19, P235, DOI 10.1007/s11102-015-0684-z
  29. Conger A, 2019, J NEUROSURG, V130, P861, DOI 10.3171/2017.11.JNS172141
  30. Coopmans EC, 2020, J CLIN ENDOCR METAB, V105, P2964, DOI 10.1210/clinem/dgaa387
  31. Cordeiro D, 2019, J NEUROSURG, V131, P1188, DOI 10.3171/2018.5.JNS18509
  32. da Cunha MLV, 2020, ENDOCRINE, V68, P182, DOI 10.1007/s12020-020-02227-2
  33. Ding D, 2019, NEUROSURGERY, V84, P717, DOI 10.1093/neuros/nyy178
  34. Dogansen SC, 2018, PITUITARY, V21, P347, DOI 10.1007/s11102-018-0877-3
  35. de los Monteros ALE, 2009, ENDOCR PRACT, V15, P431, DOI 10.4158/EP09066.ORR
  36. Fahlbusch R, 2017, PITUITARY, V20, P668, DOI 10.1007/s11102-017-0832-8
  37. Feelders RA, 2005, J CLIN ENDOCR METAB, V90, P6480, DOI 10.1210/jc.2005-0901
  38. Feola T, 2019, J CLIN ENDOCR METAB, V104, P2892, DOI 10.1210/jc.2018-02281
  39. Fleseriu M, 2019, PITUITARY, V22, P581, DOI 10.1007/s11102-019-00986-4
  40. Franck SE, 2017, EUR J ENDOCRINOL, V176, P421, DOI 10.1530/EJE-16-0956
  41. Frara S, 2020, ENDOCRIN METAB CLIN, V49, P553, DOI 10.1016/j.ecl.2020.05.010
  42. Frara S, 2016, PROG MOL BIOL TRANSL, V138, P63, DOI 10.1016/bs.pmbts.2015.10.015
  43. Gadelha MR, 2019, ENDOCR REV, V40, P268, DOI 10.1210/er.2018-00115
  44. Gadelha MR, 2014, LANCET DIABETES ENDO, V2, P875, DOI 10.1016/S2213-8587(14)70169-X
  45. Gheorghiu ML, 2017, PITUITARY, V20, P154, DOI 10.1007/s11102-016-0783-5
  46. Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526
  47. Giustina A, 2017, J ENDOCRINOL INVEST, V40, P577, DOI 10.1007/s40618-017-0614-1
  48. Giustina A, 2011, PITUITARY, V14, P125, DOI 10.1007/s11102-010-0269-9
  49. Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670
  50. GIUSTINA A, 1995, AM J CARDIOL, V75, P1042, DOI 10.1016/S0002-9149(99)80721-8
  51. Giustina A, 2020, TRENDS ENDOCRIN MET, V31, P274, DOI 10.1016/j.tem.2020.01.011
  52. Giustina A, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz096
  53. Giustina A, 2019, PITUITARY, V22, P476, DOI 10.1007/s11102-019-00977-5
  54. Giustina A, 2017, J CLIN ENDOCR METAB, V102, P2454, DOI 10.1210/jc.2017-00142
  55. Giustina A, 2015, ENDOCRINE, V48, P3, DOI 10.1007/s12020-014-0462-0
  56. Giustina A, 2013, NEUROSURGERY, V73, pE746, DOI 10.1227/NEU.0000000000000068
  57. Giustina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036411
  58. Giustina A, 2009, EUR J ENDOCRINOL, V161, P331, DOI 10.1530/EJE-09-0372
  59. Gonzales-Virla B, 2019, ENDOCRINE, V65, P386, DOI 10.1007/s12020-019-01955-4
  60. Gonzalez B, 2018, J CLIN ENDOCR METAB, V103, P2369, DOI 10.1210/jc.2018-00325
  61. Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004
  62. Ho KKY, 2019, PITUITARY, V22, P569, DOI 10.1007/s11102-019-00988-2
  63. Honegger J, 2018, PITUITARY, V21, P545, DOI 10.1007/s11102-018-0904-4
  64. Howlett TA, 2018, CLIN ENDOCRINOL, V88, P889
  65. Howlett TA, 2013, CLIN ENDOCRINOL, V79, P689, DOI 10.1111/cen.12207
  66. Jackson Y, 2019, PITUITARY, V22, P62, DOI 10.1007/s11102-018-00933-9
  67. Jane JA, 2011, J CLIN ENDOCR METAB, V96, P2732, DOI 10.1210/jc.2011-0554
  68. Kong DS, 2019, WORLD NEUROSURG, V122, pE1291, DOI 10.1016/j.wneu.2018.11.038
  69. Korkmaz OP, 2019, PITUITARY, V22, P387, DOI 10.1007/s11102-019-00968-6
  70. Lamberts SWJ, 2019, EUR J ENDOCRINOL, V181, pR173, DOI 10.1530/EJE-19-0074
  71. Espinosa-de-los-Monteros AL, 2015, PITUITARY, V18, P290, DOI 10.1007/s11102-014-0570-0
  72. Leonart LP, 2019, ENDOCRINE, V63, P18, DOI 10.1007/s12020-018-1729-7
  73. Losa M, 2016, ENDOCRINE, V52, P451, DOI 10.1007/s12020-015-0853-x
  74. Lv L, 2018, CLIN NEUROL NEUROSUR, V167, P24, DOI 10.1016/j.clineuro.2018.02.006
  75. Mazziotti G, 2010, PITUITARY, V13, P60, DOI 10.1007/s11102-009-0169-z
  76. Mazziotti G, 2009, J CLIN ENDOCR METAB, V94, P1500, DOI 10.1210/jc.2008-2332
  77. Melmed S, 2013, PITUITARY, V16, P294, DOI 10.1007/s11102-012-0420-x
  78. Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421
  79. Melmed S, 2020, NEW ENGL J MED, V382, P937, DOI 10.1056/NEJMra1810772
  80. Melmed S, 2018, NAT REV ENDOCRINOL, V14, P552, DOI 10.1038/s41574-018-0058-5
  81. Micko ASG, 2015, J NEUROSURG, V122, P803, DOI 10.3171/2014.12.JNS141083
  82. Minniti G, 2005, CLIN ENDOCRINOL, V62, P210, DOI 10.1111/j.1365-2265.2005.02199.x
  83. Mortini P, 2020, REV ENDOCR METAB DIS, V21, P527, DOI 10.1007/s11154-020-09564-7
  84. Mortini P, 2018, ENDOCRINE, V59, P72, DOI 10.1007/s12020-017-1458-3
  85. Muhammad A, 2018, J CLIN ENDOCR METAB, V103, P586, DOI 10.1210/jc.2017-02017
  86. Nunes VS, 2015, PITUITARY, V18, P500, DOI 10.1007/s11102-014-0602-9
  87. Pagliano P, 2017, INFECTION, V45, P841, DOI 10.1007/s15010-017-1056-6
  88. Perry A, 2019, WORLD NEUROSURG, V131, pE128, DOI 10.1016/j.wneu.2019.07.074
  89. Petersenn S, 2020, PITUITARY, V23, P171, DOI 10.1007/s11102-019-01020-3
  90. Petrossians P, 2017, ENDOCR-RELAT CANCER, V24, P505, DOI 10.1530/ERC-17-0253
  91. Potorac I, 2017, PITUITARY, V20, P116, DOI 10.1007/s11102-017-0788-8
  92. Puig-Domingo M, 2010, J CLIN ENDOCR METAB, V95, P4973, DOI 10.1210/jc.2010-0573
  93. Rutkowski M, 2019, NEUROSURG CLIN N AM, V30, P445, DOI 10.1016/j.nec.2019.05.005
  94. Sala E, 2018, J NEURO-ONCOL, V138, P291, DOI 10.1007/s11060-018-2793-9
  95. Samson S, 2019, J ENDOCR SOC S1, V3
  96. Samson Susan L, 2020, J Clin Endocrinol Metab, V105, DOI 10.1210/clinem/dgaa526
  97. Sandow N, 2015, PITUITARY, V18, P613, DOI 10.1007/s11102-014-0620-7
  98. Sandret L, 2011, J CLIN ENDOCR METAB, V96, P1327, DOI 10.1210/jc.2010-2443
  99. Schilbach K, 2019, EUR J ENDOCRINOL, V181, P55, DOI 10.1530/EJE-19-0139
  100. Schilbach K, 2017, PITUITARY, V20, P33, DOI 10.1007/s11102-017-0792-z
  101. Schmid HA, 2016, ENDOCRINE, V53, P210, DOI 10.1007/s12020-016-0895-8
  102. Strasburger CJ, 2018, EUR J ENDOCRINOL, V178, P321, DOI 10.1530/EJE-17-0996
  103. Suda K, 2013, ENDOCR J, V60, P507
  104. Trainer PJ, 2000, NEW ENGL J MED, V342, P1171, DOI 10.1056/NEJM200004203421604
  105. van der Lely AJ, 2020, EUR J ENDOCRINOL, V182, pD17, DOI 10.1530/EJE-19-0998
  106. van der Lely AJ, 2017, PITUITARY, V20, P692, DOI 10.1007/s11102-017-0835-5
  107. van der Lely AJ, 2016, EUR J ENDOCRINOL, V175, P239, DOI 10.1530/EJE-16-0008
  108. van der Lely AJ, 2001, LANCET, V358, P1754, DOI 10.1016/S0140-6736(01)06844-1
  109. Weidlich GA, 2019, CUREUS, V11, DOI 10.7759/cureus.4275
  110. Whitelaw B, 2019, ENDOCR-RELAT CANCER, V26, pR545, DOI 10.1530/ERC-19-0083
  111. Winograd Dina, 2020, Neurosurgery, V87, P761, DOI 10.1093/neuros/nyz555